Led · Equity · Apr 2024

Founded in 2021 by Kazi Ashikur Rasul and Arefeen Raafi Ahmed, PulseTech tackles Bangladesh’s rampant counterfeit medicine issue by sourcing drugs directly from manufacturers and delivering them to pharmacies via its Medbox platform. The company complements ordering with inventory and order-management software and arranges embedded inventory credit by linking pharmacies with financial institutions. PulseTech has scaled quickly, now serving more than 12,000 pharmacies and reaching 3.5 million people in Dhaka. While in Iterative’s accelerator, revenue jumped from US$1 million to US$13 million in just three months, underscoring strong product-market fit. With fresh capital, the company will launch its One Pharmacy franchise model to bring small, non-compliant pharmacies under a unified, compliant framework. Management also intends to expand into other South and Southeast Asian markets that face similar distribution and counterfeit-drug challenges. Ultimately, PulseTech aims to set a new standard for pharmaceutical distribution by combining logistics technology with embedded finance.

Led · Series A · Jan 2024

Sheba.xyz operates a digital marketplace for household services in Bangladesh. The platform connects consumers with providers of household services. The company recently closed a US$2.9Mn Series A round. Investors in the round include BSRM Group of Companies and Startup Bangladesh Limited. BSRM is described in the post as a leading steel manufacturer, and Startup Bangladesh Limited is identified as the country's sovereign venture capital fund. No operating metrics or future plans were disclosed in the article.

Participated · Seed · Oct 2023

Arogga operates an app-based online pharmacy and health platform in Bangladesh, offering delivery of genuine, affordable medicines and healthcare products. The app lists over 32,000 medicines from more than 500 manufacturers and serves over 600,000 users. Features include prescription upload, medicine comparison, family profiles, rewards and discounts, referral credits, a request-medicine function, and chat-based customer support. The company is positioning the app as a comprehensive health solutions platform and aims to become a holistic health super app offering lab testing and doctor consultations. Arogga plans to launch a home lab testing service in November and to increase penetration in Dhaka while opening hubs in two other major cities by Q2 2024. The startup has raised capital to support regional expansion, product development, and operations. Arogga operates a digital health platform focused on door‑to‑door medicine delivery across Bangladesh, aiming to improve access to affordable, genuine pharmaceuticals. The company emphasizes combating counterfeit drugs, which the article notes affect over 20% of medicines in Bangladeshi pharmacies. Arogga was selected for and funded through Hyper’s Season 2022 program, gaining access to a four‑week founder curriculum and Hyper’s partner network. With this raise, the company plans to bolster its technology, product, and operational teams to grow and scale its service. The article highlights a large addressable market: Bangladesh’s pharmaceutical sector is estimated at $3.5 billion and projected to reach $6 billion by 2025. Co‑founders quoted in the article include CEO Rosina Mazumder and CTO Shamim Hasan, who framed the fundraise as a step toward nationwide impact. Arogga operates a tech-enabled medicine delivery service that offers genuine medication directly from manufacturers and delivers to consumers' doorsteps. Since launching in December 2020, the company has seen strong traction with a reported 60% average month-on-month growth. Operational metrics cited include over 70,000 app downloads, more than 30,000 medicines delivered, and a 4.9 user rating. Arogga won the Tech in Asia Pitch Competition in March, which attracted investment from Singapore-based angel investors. The team says it will use new funds to expand its tech talent and scale operations to build further verticals. Leadership emphasizes using technology to improve healthcare access across Bangladesh.

Participated · Seed · Sep 2023

MedEasy operates an online pharmacy platform from Dhaka, Bangladesh that aims to make authentic medicines and consultations more accessible. The company says it has gained the trust of over 150,000 users within two years of inception, demonstrating early traction in the Bangladeshi healthcare market. MedEasy positions itself as a digital lifeline for chronic and underserved patient segments through a data-driven approach. The startup plans product expansions including a subscription feature, a digital vital monitoring system, and an appointment-booking marketplace. Management intends to use new funding to bolster customer acquisition, refine operations, enhance platform features, and support R&D. Investors have highlighted MedEasy’s focus on addressing Bangladesh’s specific healthcare challenges for chronic patients.

Led · Equity · Dec 2022

Bimafy is a digital insurance platform in Bangladesh that enables customers to access and purchase insurance through its app and website. Customers can choose and buy health, accident, travel and motor insurance from insurers of their choice via the platform. The company also offers corporate solutions and works closely with multiple companies to provide a variety of business-focused insurance services. Since 2019, Bimafy has been working on digitalisation of insurance service facilities to ensure global-standard customer service. It provides digital insurance services to more than 400,000 customers and settles health insurance claims through innovative micro-insurance products. Recently Bimafy received an investment worth BDT 1 Crore from Startup Bangladesh Limited.